Edward M. Rudnic,James D. Isbister,Donald J. Treacy, JR.,Sandra E. Wassink
申请号：
US13273966
公开号：
US20120035121A1
申请日:
2011.10.14
申请国别(地区):
US
年份:
2012
代理人:
摘要：
An antibiotic product is comprised of at least two dosages forms, each of which has a different release profile, with the Cmax for the antibiotic product being reached in less than about twelve hours. In one embodiment, there is an immediate release dosage form, as well as one or more delayed release dosage forms, with each of the dosage forms having a different release profile, wherein each reaches a Cmax at different times.
